Európska únia - slovenčina - EMA (European Medicines Agency)

janssen-cilag international n.v. - telaprevir - hepatitída c, chronická - antivirotiká na systémové použitie - incivo, v kombinácii s peginterferon alfa a ribavirin, je indikovaný na liečbu genotyp-1 chronickej hepatitídy c u dospelých pacientov s kompenzované ochorenie pečene (vrátane cirhózy):kto sú liečby insitného;ktorí boli predtým liečení interferónom alfa (pegylated alebo non-pegylated) samostatne alebo v kombinácii s ribavirin, vrátane relapsers, čiastočná respondentov a null respondentov.

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

pharmanovia a/s, dánsko - Ópium - 49 - digestiva, adsorbentia, acida

Európska únia - slovenčina - EMA (European Medicines Agency)

nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - antibakteriálne pre systémové použitie, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. je treba vziať do úvahy oficiálne usmernenie o vhodnom používaní antibakteriálne agentov.

Európska únia - slovenčina - EMA (European Medicines Agency)

gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.

Európska únia - slovenčina - EMA (European Medicines Agency)

astellas pharma europe b.v. - enzalutamide - prostatické nádory - endokrinná terapia - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

krka, d.d., novo mesto, slovinsko - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

fresenius kabi s.r.o., Česká republika - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

fresenius kabi s.r.o., Česká republika - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sandoz pharmaceuticals d.d., slovinsko - enzalutamid - 44 - cytostatica

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sandoz pharmaceuticals d.d., slovinsko - enzalutamid - 44 - cytostatica